Loading advertisement
Logo
  • Shop Now
  • Help
  • Handicapping & PPs
  • Entries
  • Results
  • News & Info
  • Saratoga
  • Breeding
  • Harness
  • Help
  • Shop
  • DRF en Español
  • DRF Recommends
  • Bet on Sports
  • DRF Pro Services
  • DRF Form Finder
Track Pages
Horse Racing News
Stakes Races
DRF TV
Race of the Day
International Racing
Beyer Speed Figures
DRF En Espanol

Gamine disqualified from Kentucky Oaks placing, Baffert fined $1,500

Matt Hegarty|Feb 05, 2021
Gamine finishes third in the Kentucky Oaks at Churchill Downs
Barbara D. Livingston Gamine tested over the permitted level for a regulated corticosteroid following her third-place finish in the Grade 1 Kentucky Oaks.

Gamine, the champion female sprinter of 2020, has been disqualified from her third-place finish in the Grade 1 Kentucky Oaks at Churchill Downs on Sept. 4 for a positive of the regulated corticosteroid betamethasone, according to a ruling from Kentucky’s stewards.

Bob Baffert, the filly’s trainer, was also fined $1,500 for the positive. The ruling from the stewards noted that Baffert waived his right to appeal.

With the disqualification, Gamine’s 2020 record is now marred by two regulatory actions for post-race positives. She was also disqualified from a winning effort in an allowance-optional claiming race at Oaklawn Park in Arkansas in early May, the second race of her career.

Gamine tested positive for lidocaine in that race, and Baffert has appealed the ruling, contending that the positive was an inadvertent contamination from a stable employee who was wearing a lidocaine patch. Another horse in Baffert’s barn, Charlatan, also tested positive for lidocaine after winning that day at Oaklawn.

Betamethasone, an anti-inflammatory drug, is a Class C drug in Kentucky and one of the most commonly used corticosteroids in racing. The drug is currently not permitted to be administered within 14 days of a race. Under the KHRC’s guidelines, the recommended penalty for a positive is a $1,000 fine “absent mitigating circumstances.”

Craig Robertson, Baffert’s lawyer, said in a previous statement that Gamine was administered betamethasone 18 days prior to the Oaks.

The KHRC eliminated threshold levels on corticosteroids in August of last year, as part of a larger effort to tighten restrictions on the administration of the drugs. When the thresholds were eliminated, the KHRC amended its withdrawal guidelines on corticosteroids from seven days prior to a race to 14 days.

Gamine concluded her 2020 campaign with a 6 1/4-length victory in the Breeders’ Cup Filly and Mare Sprint, at even-money. She was credited with four wins from six starts, and earnings of just over $1 million.

Gamine remains in training with Baffert and is readying for the start of her 2021 campaign.

DRF Headlines

View All 
Stay Updated Now

Get the latest racing news, expert picks, and exclusive analysis delivered to your inbox.

Sign Up for Newsletter

Interested in News?

Google News

Download DRF app on your smartphone.

Download appDownload app

Events

  • Saratoga
  • Del Mar
  • Hong Kong
  • More

News

  • Race of the Day
  • Track Pages
  • Latest News
  • Breeding
  • More

Tracks

  • Del Mar
  • Gulfstream Park
  • Saratoga
  • Woodbine

Handicapping & PPs

  • DRF Classic PPs
  • Formulator PPs
  • TimeformUS PPs
  • Daily Racing
Program
  • DRF Picks
  • More
Drf en espanolPurchase ppspreference center
Drf en espanolPurchase ppspreference center

© 2026 Daily Racing Form.  All rights reserved.

Careers
Help
Terms
Privacy

© 2026 Daily Racing Form.  All rights reserved.